Powered by
-Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences

Devon, PA- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that Armando Anido, Chairman and Chief Executive Officer, will present at upcoming investor conferences in March, including:

29th Annual ROTH Conference in Orange County, CA, on March 13, 2017 at 1:00 pm PT (4:00 pm ET)

Oppenheimer & Co. 27th Annual Healthcare Conference in Ne

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox